Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

100.0%

3 terminated/withdrawn out of 3 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT02689635Not ApplicableTerminated

Low Sodium vs. Regular Diet in Patients Admitted for Heart Failure

Role: lead

NCT02304705Phase 4Terminated

Sildenafil in Heart Failure With Reactive Pulmonary Hypertension

Role: lead

NCT02694289Not ApplicableWithdrawn

Effects of Metformin in Heart Failure Patients

Role: lead

All 3 trials loaded